Realbotix Reports Financial Results for Q2-2026
Go back to Realbotix Reports Financial Results for Q2-2026| Oncology Med, Inc. (NASDAQ: ONCO) | Delayed: 0.43 +0.02 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.41 | 52 Week High | $0.00 | |||
| Open | $0.43 | 52 Week Low | $0.00 | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.41 | EPS | $0.00 | |||
| Volume | 624,994 | |||||
| (AMEX: XBOTF) | Delayed: 0.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.17 | 52 Week High | $ | |||
| Open | $0.17 | 52 Week Low | $ | |||
| Day High | $0.18 | P/E | N/A | |||
| Day Low | $0.16 | EPS | $ | |||
| Volume | 191,902 | |||||



